Facebook
Twitter
LinkedIn
ForwardPULSE: Taking the sting out of buprenorphine for chronic pain management - January 6, 2020
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications.
Target Audience
Pharmacists at UPMC, Pharmacy Faculty at PittPharmacy, Pharmacy Residents, Pharmacy Students
Learning Objectives
1. List 3 barriers to buprenorphine’s role in chronic noncancer pain management
2. Explain the strength of recommendation and differentiate gaps within supporting evidence for buprenorphine use between two different patient populations
3. Given a scenario, identify at least one population in which buprenorphine therapy would be appropriate
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications.
Carly Gabriel, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.